{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.210",
  "meta": {
    "versionId": "12",
    "lastUpdated": "2022-01-12T01:02:12.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210",
  "version": "20220112",
  "name": "Capecitabine Oral",
  "status": "active",
  "date": "2022-01-12T01:02:12-05:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "200327",
            "display": "capecitabine 150 MG Oral Tablet"
          },
          {
            "code": "200328",
            "display": "capecitabine 500 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:c674a036-7bfc-41db-967e-6dd826643208",
    "timestamp": "2022-06-10T05:27:17-04:00",
    "total": 2,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "code": "200327",
        "display": "capecitabine 150 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "code": "200328",
        "display": "capecitabine 500 MG Oral Tablet"
      }
    ]
  }
}